Smart Money Alert

Indegene Limited

New PositionBlock Deal

INDGNHealthcare Research, Analytics & TechnologyMarket Cap₹15K Cr

Deal value

₹34.92 Cr

Deal price

₹525.00

6.65 L

Trade date

6 Aug 2026

Since alert+10.8%₹554.45 → ₹614.60

Nifty 50+1.9%

Morgan Stanley

Foreign Investor

The move

Morgan Stanley bought 665,048 shares of Indegene Limited in a block deal on August 6, 2026, for ₹34.92 crore at ₹525.00 apiece.

About Indegene Limited

+ Follow Visit stock

A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.

About Morgan Stanley

+ Follow Visit investor

US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.

Follow Morgan Stanley and Indegene Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Indegene Limited shareholders Morgan Stanley's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Indegene Limited